Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 4
1954 36
1955 79
1956 87
1957 135
1958 240
1959 240
1960 47
1961 59
1962 52
1963 101
1964 152
1965 76
1966 94
1967 91
1968 127
1969 96
1970 123
1971 99
1972 127
1973 107
1974 117
1975 139
1976 114
1977 138
1978 109
1979 118
1980 112
1981 127
1982 101
1983 117
1984 143
1985 133
1986 140
1987 129
1988 118
1989 131
1990 153
1991 140
1992 159
1993 146
1994 155
1995 139
1996 181
1997 130
1998 170
1999 156
2000 151
2001 159
2002 157
2003 134
2004 176
2005 159
2006 154
2007 136
2008 168
2009 181
2010 186
2011 183
2012 202
2013 228
2014 234
2015 234
2016 268
2017 273
2018 257
2019 249
2020 259
2021 239
Text availability
Article attribute
Article type
Publication date

Search Results

9,562 results
Results by year
Filters applied: . Clear all
Page 1
Evaluating off-label uses of acetazolamide.
Van Berkel MA, Elefritz JL. Van Berkel MA, et al. Am J Health Syst Pharm. 2018 Apr 15;75(8):524-531. doi: 10.2146/ajhp170279. Am J Health Syst Pharm. 2018. PMID: 29626002 Review.
PURPOSE: Current off-label uses of acetazolamide in hospitalized patients are reviewed. SUMMARY: Acetazolamide is a carbonic anhydrase inhibitor typically used for indications including epilepsy, glaucoma, edema, and altitude sickness but it may be prescribed in hos …
PURPOSE: Current off-label uses of acetazolamide in hospitalized patients are reviewed. SUMMARY: Acetazolamide is a carbonic a …
Acetazolamide for the treatment of idiopathic intracranial hypertension.
Supuran CT. Supuran CT. Expert Rev Neurother. 2015;15(8):851-6. doi: 10.1586/14737175.2015.1066675. Epub 2015 Jul 7. Expert Rev Neurother. 2015. PMID: 26154918 Review.
The sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor (CAI) acetazolamide (AAZ), a compound developed in the 1950s as a diuretic drug and presently used as an antiglaucoma, antiepileptic and diuretic agent, is effective in the treatment of IIH. ...
The sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor (CAI) acetazolamide (AAZ), a compound developed in the 1950s as a diure …
Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons.
Adamson R, Swenson ER. Adamson R, et al. Ann Am Thorac Soc. 2017 Jul;14(7):1086-1093. doi: 10.1513/AnnalsATS.201701-016FR. Ann Am Thorac Soc. 2017. PMID: 28622013 Review.
Acetazolamide is a carbonic anhydrase (CA) inhibitor sometimes used as a respiratory stimulant for patients with chronic obstructive pulmonary disease (COPD) with the goal of improving oxygenation, reducing carbon dioxide retention, and aiding liberation from mechanical ve
Acetazolamide is a carbonic anhydrase (CA) inhibitor sometimes used as a respiratory stimulant for patients with chronic obstructive
[Acetazolamide].
Walstad RA. Walstad RA. Tidsskr Nor Laegeforen. 1990 Apr 30;110(11):1376-7. Tidsskr Nor Laegeforen. 1990. PMID: 2339384 Norwegian. No abstract available.
[Acetazolamide].
Ab CN, Gatenbeck L, Olsson O. Ab CN, et al. Tidsskr Nor Laegeforen. 1990 Nov 30;110(29):3794-5. Tidsskr Nor Laegeforen. 1990. PMID: 2274959 Norwegian. No abstract available.
[Acetazolamide].
Walstad RA. Walstad RA. Tidsskr Nor Laegeforen. 1990 Dec 10;110(30):3961-2. Tidsskr Nor Laegeforen. 1990. PMID: 2281466 Norwegian. No abstract available.
Chlorothiazide.
CRAWFORD JD. CRAWFORD JD. Pediatrics. 1958 Aug;22(2):236-7. Pediatrics. 1958. PMID: 13578508 No abstract available.
Acetazolamide in the treatment of seizures.
Reiss WG, Oles KS. Reiss WG, et al. Ann Pharmacother. 1996 May;30(5):514-9. doi: 10.1177/106002809603000515. Ann Pharmacother. 1996. PMID: 8740334 Review.
OBJECTIVE: To summarize the pharmacology, pharmacokinetics, efficacy, and safety of acetazolamide and to evaluate its therapeutic role in patients with epilepsy. ...Topics investigated included basic pharmacology, therapeutics, toxicology, adverse reactions, dosage, admini …
OBJECTIVE: To summarize the pharmacology, pharmacokinetics, efficacy, and safety of acetazolamide and to evaluate its therapeutic rol …
Acetazolamide: a forgotten diuretic agent.
Kassamali R, Sica DA. Kassamali R, et al. Cardiol Rev. 2011 Nov-Dec;19(6):276-8. doi: 10.1097/CRD.0b013e31822b4939. Cardiol Rev. 2011. PMID: 21983315 Review.
Acetazolamide is the only carbonic anhydrase inhibitor with significant diuretic effects. ...Acetazolamide can, however, correct the significant metabolic alkalosis which occasionally occurs with loop diuretic therapy....
Acetazolamide is the only carbonic anhydrase inhibitor with significant diuretic effects. ...Acetazolamide can, however, corre
[Acetazolamide--are there reasons for its revival in antiepileptic treatment?].
Hoddevik GH. Hoddevik GH. Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1042-5. Tidsskr Nor Laegeforen. 2000. PMID: 10833964 Review. Norwegian.
BACKGROUND: Since 1950 the carbonic anhydrase inhibitor acetazolamide has been used as an antiepileptic drug. Because of its tolerance developing properties, acetazolamide has probably been bypassed by the new antiepileptic drugs on the market. ...As an additional d …
BACKGROUND: Since 1950 the carbonic anhydrase inhibitor acetazolamide has been used as an antiepileptic drug. Because of its toleranc …
9,562 results